Results 301 to 310 of about 386,289 (317)
Some of the next articles are maybe not open access.
Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis
International Journal of Clinical Oncology, 2017The aim of the present study was to elucidate the details of bone metastasis (BM) and the resulting skeletal-related events (SREs), and survival and prognostic factors, in urothelial cancer (UC) patients with BM.A total of 48 UC patients with BM who were treated at our institution between 1994 and 2013 were enrolled.
Yusuke Tsuda +11 more
openaire +2 more sources
Update on the Pharmacological Prevention of Skeletal-related Events in Cancer Patients
Orthopedics, 2011Metastases to the bone are a frequent complication of advanced cancer. Bone metastases have been linked to skeletal-related events, which is the composite endpoint used in clinical trials evaluating therapy to minimize these complications. This article discusses bisphosphonates, which are the historical standard for the prevention of skeletal-related ...
Kenneth, Kennedy, Hetalkumari, Patel
openaire +2 more sources
Bone Health: Prevention of Skeletal-Related Events and Palliative Care
2012Bone health in patients with prostate cancer has been an ever-growing field for almost a decade now. Beyond the realization that patients with prostate cancer suffer from osteopenia at the outset and need some sort of regimen to maintain their bone density, it is becoming increasingly clear that bone decay related to hormonal therapies can result in ...
Jean-Baptiste Lattouf, Fred Saad
openaire +1 more source
Analysis of skeletal-related events in breast cancer and response to therapy
Seminars in Oncology, 2001The skeleton is a common site for the spread of metastatic cancer and skeletal complications are a cause of significant morbidity and mortality. Treatment of skeletal morbidity is therefore an essential component of therapy for cancer patients with bone metastases. Bisphosphonates are currently the treatment of choice for skeletal complications.
openaire +2 more sources
Minimally Invasive Treatment of Skeletal-Related Events
2023Amata Thongphetsavong Gautam +1 more
openaire +1 more source
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.
Oncology (Williston Park, N.Y.), 2015Skeletal-related events contribute substantially to morbidity, mortality and cost in men with metastatic castration-resistant prostate cancer (mCRPC). There are five agents available for treatment in mCRPC that reduce skeletal-related events. Here we discuss the efficacy and safety of zoledronic acid, denosumab, enzalutamide, abiraterone, and radium ...
Julie N, Graff, Tomasz M, Beer
openaire +1 more source
Decreased incidence of skeletal-related events in mRCC
Nature Reviews Urology, 2014Takeshi Yuasa, Shinji Urakami
openaire +1 more source